PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer.
Affiliation
Institute of Cancer Sciences, University of Manchester; Department of Academic Surgery, University Hospital of South ManchesterIssue Date
2016-04
Metadata
Show full item recordAbstract
Circulating tumour cells (CTCs) are a marker of poor prognosis and are associated with increased risk of venous thromboembolism in metastatic breast cancer.Citation
PO-31 - Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer. 2016, 140 Suppl 1:S188 Thromb ResJournal
Thrombosis ResearchDOI
10.1016/S0049-3848(16)30164-5PubMed ID
27161721Type
ArticleLanguage
enISSN
1879-2472ae974a485f413a2113503eed53cd6c53
10.1016/S0049-3848(16)30164-5